<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03915041</url>
  </required_header>
  <id_info>
    <org_study_id>RC17_0390</org_study_id>
    <nct_id>NCT03915041</nct_id>
  </id_info>
  <brief_title>Effects of tDCS Combined With VR on Anxious Ruminations in Healthy Subjects With a Vulnerability to Rumination</brief_title>
  <acronym>REVISTIM-XX</acronym>
  <official_title>Effects of tDCS Combined With Virtual Reality on Anxious Ruminations in Healthy Subjects With a Vulnerability to Rumination</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study proposes: to evaluate 1) whether the combination of virtual reality (VR) and
      active tDCS provides better rumination attenuation than the combination of VR and tDCS
      placebo 2) the acceptability and experiential experience of combining these two well known
      medical devices.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion visit:

        -  Confirmation of eligibility criteria

        -  Written informed consent

      Visit 1 and 2 (or end of study visit) :

      Before first ruminations induction :

        -  Completion of Brief State Rumination Inventory (BSRI), State-Trait Anxiety (STAI),
           Inventory, Visual Analogic Scale (VAS), Ruminative Response Scale - Short Form (RRS-SF),
           Beck depression Inventory (BDI)

        -  EEG recording

      Then Procedure for inducing ruminations using a pre-recorded voice listened to in an audio
      headset alternating statements promoting a positive, neutral and negative introspection and
      self-judgment attitude (the latter are heard at the end to initiate the rumination process)
      over 8 minutes

      Then

        -  Completion of Brief State Rumination Inventory (BSRI), Inventory, Visual Analogic Scale
           (VAS), Beck depression Inventory (BDI),

        -  EEG recording

        -  Pulse and blood pressure measurements

      Then immersion in a relaxing virtual environment for 20 minutes with active or sham placebo.

      â€¢ Cutaneous conductance measurement and eye-tracking during immersion

      At the end of immersion :

        -  Completion of Brief State Rumination Inventory (BSRI), Inventory, Visual Analogic Scale
           (VAS), Beck depression Inventory (BDI), IGroup presence questionnaire (IPQ)

        -  Pulse and blood pressure measurements

      Then again procedure for inducing ruminations .

      At the end of ruminations induction :

        -  Completion of Brief State Rumination Inventory (BSRI), State-Trait Anxiety (STAI),
           Inventory, Visual Analogic Scale (VAS), Beck depression Inventory (BDI), tolerance
           questionnaires

        -  Debriefing
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 15, 2019</start_date>
  <completion_date type="Anticipated">August 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in anxious ruminations after anodal tDCS and virtual reality</measure>
    <time_frame>within 1 week</time_frame>
    <description>Change in anxious ruminations after anodal tDCS and virtual reality will be evaluated to compare the effects of tDCS associated with virtual reality versus virtual reality alone (+ tDCS placebo) to reduce ruminations.
Evaluate with Brief State Ruminative Inventory (BSRI). It is a scale with 8 items. Each item is VAS with a score ranging between 0 and 100. The total score is sum of each item score (Total /800)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Rumination</condition>
  <arm_group>
    <arm_group_label>VR + active brain stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Exposure to a virtual reality world with active transcranial electric stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VR + sham brain stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Exposure to a virtual reality world with sham transcranial electric stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VR + active brain stimulation</intervention_name>
    <description>Active Brain stimulation (tDCS) is applied during exposition to virtual reality (20 minutes)</description>
    <arm_group_label>VR + active brain stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VR +sham brain stimulation</intervention_name>
    <description>Sham Brain stimulation (tDCS) is applied during exposition to virtual reality (20 minutes)</description>
    <arm_group_label>VR + sham brain stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Without any particular ethnic and psychosocial criteria

          -  Subject to ruminations (personality trait) documented by a RRS-SF score &gt;30

          -  Subjects with score to BDI scal &lt;14 assessed during first visit

          -  Subjects without psychiatric or addictive disorders.

          -  Subjects who do not meet all the diagnostic criteria for an anxiety disorder or
             characterized depressive episode.

        Exclusion Criteria:

          -  contraindication to tDCS (neurosurgical history, intracranial device, skin problems)

          -  current virtual reality intolerance

          -  history of psychiatric or addictive disorders

          -  Use of psychotropic drugs

          -  Use of non psychotropic treatments significantly influencing mood or level of anxiety

          -  pregnant or breast-feeding women

          -  Neurological pathology, locomotor disability, or sensory (vestibular, visual, auditory
             ...)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BULTEAU</last_name>
      <phone>2 40 08 47 95</phone>
      <phone_ext>+33</phone_ext>
      <email>samuel.bulteau@chu-nantes.fr</email>
    </contact>
    <contact_backup>
      <email>bp-revistim@chu-nantes.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Samuel BULTEAU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>February 18, 2019</study_first_submitted>
  <study_first_submitted_qc>April 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2019</study_first_posted>
  <last_update_submitted>November 15, 2019</last_update_submitted>
  <last_update_submitted_qc>November 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>virtual reality</keyword>
  <keyword>brain stimulation</keyword>
  <keyword>tDCS</keyword>
  <keyword>phenomenology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Feeding and Eating Disorders of Childhood</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

